What Researchers Did
Researchers reviewed data from 13 patients with MRI-proven acute spinal cord infarction (SCI) at Fiona Stanley Hospital from 2014-2019 to describe their characteristics and outcomes, including the utilization of hyperbaric oxygen treatment (HBOT), cerebrospinal fluid (CSF) drainage, and pentoxifylline.
What They Found
The study identified 13 patients with acute SCI, with a median age of 57 years and 54% being female. Five patients received HBOT within a median of 40 hours from symptom onset, averaging 15 treatments, and three of these also received triple therapy (HBOT, pentoxifylline, CSF drainage), showing favorable outcomes with a median Medical Research Council manual muscle testing power of 5 and a modified Rankin Score of 1.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen treatment, potentially combined with pentoxifylline and cerebrospinal fluid drainage, could be considered as a therapeutic option for Canadian patients experiencing acute spinal cord infarction, especially given the lack of established treatment guidelines. While further research is needed, these findings offer insights into potential management strategies that might improve outcomes for individuals with this devastating condition.
Canadian Relevance
This study was conducted in Australia and has no direct Canadian connection.
Study Limitations
The main limitation of this study is its small sample size of 13 patients and its descriptive, retrospective nature, which prevents definitive conclusions about treatment efficacy.